Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial assessing nabilone for attenuation of anorexia and improvements in nutritional status and quality of life in …
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating consolidation therapy with fulvestrant and anastrozole in postmenopausal women with advanced non-small cel…
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: TF2- Small Cell Lung Cancer Radio Immunotherapy [Phase 1, Phase 2]
The clinical trial TF2 radioimmunotherapy for small cell lung cancer and non-small cell lung cancer has completed Phase 1 and Phase 2 studie…
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation [Phase 3]
Phase 3 trial evaluating first-line icotinib with concurrent radiotherapy in EGFR-mutant non-small cell lung cancer; current status is unkno…
-
CLINICAL_TRIALS trial_result · 2016-08-29Clinical Trial Update: Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases [Phase 1]
This Phase 1 trial assessed the maximum tolerated dose of vandetanib when given with whole brain radiotherapy in patients with non-small cel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-26Clinical Trial Update: Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC [Phase 1]
This Phase I trial update describes two cisplatin-based regimens—vinorelbine plus cisplatin and gemcitabine plus cisplatin—for locally advan…
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) [Phase 2]
This document reports the completion of a Phase 2 trial evaluating ZD6474 (vandetanib) alone or in combination with paclitaxel and carboplat…
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer. [Phase 2]
This document reports a completed Phase 2 trial evaluating the efficacy and safety of ZD6474 in patients with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: ZD6474 Phase IIa Dose Finding Multicentre Study [Phase 2]
Genzyme, a Sanofi company, sponsored a completed Phase IIa dose-finding multicentre study of ZD6474 (vandetanib) in non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study [Phase 3]
A multicenter Phase 3 randomized study comparing whole-brain radiation therapy alone to erlotinib given with WBRT as first-line treatment in…
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: ZD6474(Vandetanib) + Alimta Combo Study [Phase 1]
A Phase 1 study evaluating Vandetanib (ZD6474) in combination with Alimta (pemetrexed) for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC. [Phase 2]
A Phase 2 trial comparing the efficacy of ZD6474 (vandetanib) and ZD1839 (gefitinib) in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer [Phase 4]
Phase 4 trial update of Tarceva (erlotinib) as first- or second-line treatment in advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating Avastin (bevacizumab) with platinum-based chemotherapy for advanced or recurrent squamous non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation Therapy
A registry study evaluating thoracic reirradiation for non-small cell lung cancer using proton beam therapy or intensity-modulated radiation…
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Results from a Phase 1/2 study of MM-121 in combination therapy for advanced non-small cell lung cancer have been posted. The trial, sponsor…
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 clinical trial evaluating detection of circulating endothelial progenitor cells in non-small cell lung cancer; the study status is c…
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO [Phase 2]
Phase 2 trial of dacomitinib in advanced non-small cell lung cancer evaluating prophylactic interventions for dermatologic and gastrointesti…
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy and radiation with or without panitumumab in stage IIIA non-small cell lung cancer has completed with …
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies [Phase 1, Phase 2]
Phase 1/Phase 2 trial results update for alisertib in adults with advanced nonhematological malignancies, including non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy. [Phase 2]
This update reports the completion of a Phase 2 study evaluating Mircera for anemia in patients with non-small cell lung cancer receiving fi…
-
CLINICAL_TRIALS trial_result · 2016-08-09Clinical Trial Update: EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism [Phase 3]
Phase 3 trial update evaluating an EGFR-TKI with chemotherapy in non-small cell lung cancer patients who have both an EGFR mutation and BIM …
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: T790M Mutation on ctDNA in Patients With NSCLC After EGFR-TKI Failure
A completed clinical trial evaluated detection of EGFR T790M mutation in circulating tumor DNA from patients with non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: Apatinib Combined With Docetaxel Monotherapy as Second-line Therapy of Advanced EGFR WT, Non-squamous NSCLC
This clinical trial update reports the evaluation of apatinib combined with docetaxel as a second-line treatment for advanced EGFR wild-type…
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: A Study of Erlotinib (Tarceva) in Participants With Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 study of Erlotinib (Tarceva) in participants with non-small cell lung cancer has completed, and results have been posted.